Stephanie A Duench, L Hannah Gould, Alexandra Kissling, Kathleen Beusterien, Lewis Kopenhafer, Gabriela Burgos
People of color may face distinct challenges in Lyme disease recognition and management, contributing to disparities in outcomes. Findings underscore the need for targeted education for at-risk populations, patients, and providers and for equitable prevention and diagnostic strategies.
OBJECTIVES: Lyme disease is the most common vector-borne illness in the United States, with an estimated 476,000 cases diagnosed and treated annually. Although incidence is highest among White individuals, people of color are more likely to experience severe or disseminated manifestations. This study explored factors contributing to this disparity by examining experiences of people of color diagnosed with Lyme disease.
SETTING: Participants resided in high-incidence U.S. states.
PARTICIPANTS: Self-identified people of color diagnosed with Lyme disease within the past 12 months.
METHODS: Fifteen participants completed in-depth interviews analyzed using inductive and deductive qualitative content analysis. Follow-up focus groups supported consensus-building and thematic refinement.
RESULTS: Key themes included limited awareness that people of color are at risk for Lyme disease, perceived discrimination in healthcare encounters, diagnostic delays attributed to the characteristic erythema migrans (EM) rash being less visible on darker skin, and insufficient physician knowledge regarding diverse clinical presentations. Participants also expressed a preference for racially concordant providers. Lyme disease affected physical health, emotional well-being, social relationships, and engagement in outdoor activities.
CONCLUSIONS: People of color may face distinct challenges in Lyme disease recognition and management, contributing to disparities in outcomes. Findings underscore the need for targeted education for at-risk populations, patients, and providers and for equitable prevention and diagnostic strategies.